We are live on ! Find out more
AC

Adelphi Capital Portfolio holdings

AUM $3.21M
1-Year Est. Return 121.6%
This Fund
S&P 500
This Quarter Est. Return
+6.94%
1 Year Est. Return
+121.6%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$515M
AUM Growth
+$461K
Cap. Flow
-$24.6M
Cap. Flow %
-4.77%
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
–
Reduced
3
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
TAK icon
Takeda Pharmaceutical
TAK
+$12.1M
2
RYAAY icon
Ryanair
RYAAY
+$6.85M
3
FIS icon
Fidelity National Information Services
FIS
+$5.65M

Sector Composition

Rank Sector Weight
1 Technology 49.12%
2 Healthcare 26.79%
3 Industrials 24.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FIS icon
1
Fidelity National Information Services
FIS
$22.5B
$253M 49.12%
1,789,151
-39,576
-2% -$5.65M
TAK icon
2
Takeda Pharmaceutical
TAK
$55.8B
$138M 26.79%
7,584,930
-689,297
-8% -$12.1M
RYAAY icon
3
Ryanair
RYAAY
$30B
$124M 24.09%
2,821,378
-174,482
-6% -$6.85M

Similar funds

TA
TA Associates Boston, Massachusetts $4.01M AUM 59.82% 1-Year Est. Return
TAM
Trikon Asset Management Hong Kong $1.84M AUM 172.11% 1-Year Est. Return
TMC
TVL Management Corporation Menlo Park, California $1.84M AUM 0.1% 1-Year Est. Return
AV
Arboretum Ventures Ann Arbor, Michigan $1.72M AUM 82.7% 1-Year Est. Return
MVPI
Maven Ventures Partners II Palo Alto, California $958K AUM 41.74% 1-Year Est. Return
RIA
RP Investment Advisors Toronto, Ontario, Canada $900K AUM 17.98% 1-Year Est. Return
IAC
ION Acquisition Corp Herzliya, Israel $5.63M AUM 38.71% 1-Year Est. Return
ALBM
Alcentra Ltd (BNY Mellon) London, United Kingdom $566K AUM 51.56% 1-Year Est. Return

Adelphi Capital's Q4 2020 Portfolio in Review

As of Q4 2020, Adelphi Capital held 3 positions worth $515M, up 0.09% from $515M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Adelphi Capital withdrew a net $24.6M in Q4 2020, reducing 3 holdings. Its largest reduction was Takeda Pharmaceutical, cutting an estimated $12.1M.

By sector, the portfolio is most concentrated in Technology at 49% of assets, down from 52% a quarter earlier, followed by Healthcare and Industrials.

  • Adelphi Capital's biggest Q4 2020 reduction was Takeda Pharmaceutical, cutting an estimated $12.1M.
  • Adelphi Capital's ten largest holdings make up 100% of its $515M portfolio in Q4 2020.
  • Adelphi Capital opened 0 new positions and closed 0 in Q4 2020.
  • Adelphi Capital's portfolio value rose 0.09% quarter-over-quarter to $515M.

Based on Adelphi Capital's 13F filing for Q4 2020, filed 25 Jan 2021.